PARIS, March 13, 2023 (BSS/AFP) - US pharmaceutical giant Pfizer announced Monday it reached a deal to buy biotech firm Seagen, specialising in innovative cancer treatment, for $43 billion. 

     "Pfizer is deploying its financial resources to advance the fight against cancer," said Pfizer CEO Albert Bourla.